Extracellular vesicles derived from inflammatory-educated stem cells reverse brain inflammation-implication of miRNAs
Extracellular vesicles derived from inflammatory-educated stem cells reverse brain inflammation-implication of miRNAs
复制标题
来自炎症教育干细胞的细胞外小泡逆转脑炎症--miRNAs的意义
DOI:
10.1016/j.ymthe.2021.08.008
复制
发表时间:
2022-01-05
影响因子:
12.4
通讯作者:
Mohapatra, Subhra
中科院分区:
文献类型:
--
作者:
Markoutsa, Eleni;Mayilsamy, Karthick;Mohapatra, Subhra
Inflammation plays a key role in the development of age-related diseases. In Alzheimer's disease, neuronal cell death is attributed to amyloidbeta oligomers that trigger microglial activation. Stem cells have shown promise as therapies for inflammatory diseases-because of their paracrine activity combined with their ability to respond to the inflammatory environment. However, the mechanisms underlying stem cell-promoted neurological recovery are poorly understood. To elucidate these mechanisms, we first primed stem cells with the secretome of lipopolysaccharide- or amyloidbeta-activated microglia. Then, we compared the immunomodulatory effects of extracellular vesicles (EVs) secreted from primed and nonprimed stem cells. Our results demonstrate that EVs from primed cells are more effective in inhibiting microglia and astrocyte activation, amyloid deposition, demyelination, memory loss and motor and anxiety-like behavioral dysfunction, compared to EVs from non-primed cells. MicroRNA (miRNA) profiling revealed the upregulation of at least 19 miRNAs on primed-stem cell EVs. The miRNA targets were identified, and KEGG pathway analysis showed that the overexpressed miRNAs target key genes on the toll-like receptor-4 (TLR4) signaling pathway. Overall, our results demonstrate that priming mesenchymal stem cells (MSCs) with the secretome of activated microglia results in the release of miRNAs from EVs with enhanced immune regulatory potential able to fight neuro-inflammation.